Synthetic Gels
to Standardize
Patient-Derived Organoids

QGel Technology Explained
What is the QGel
Proprietary Technology

QGel constructs tunable synthetic extracellular matrices (ECMs) for in vitro cellular based studies. QGel disease models recapitulate desired key physiological features of the human body and support the culture of any cell type, including:

Freshly isolated patient cells • Patient-derived organoids • Cells from PDX • Cell lines

QGel cell based assays can be used for applications in:

Clinical decision making • Drug discovery • Basic research

Benefits of synthetic ECMs:

Reproducible • Industrially scalable • Fully defined • Amenable to regulatory approval

 

Find out more
Working
with QGel

Order online

QGel has a range of cell line specific ECMs ready to ship. Visit our webshop and browse by any number of filter options. Each product comes with easy to use protocols to ensure the seamless integration of assays into your labs.

Visit the webshop
or

Design custom disease models

QGel works with a number of industry partners to develop organoid models for a range of applications. See how we screen our library of gels to find organoid culture conditions that work for you.

Learn about our ECM ID Program

Our Vision and Mission

At QGel, we are passionate about providing solutions for the discovery of next generation drugs and accelerating patient access to personalized medicine.

QGel’s Vision

Cancer is a manageable disease

QGel’s Mission

To harness reliable information from patient biological samples, enable breakthroughs in personalized medicine and ultimately improve or save lives of cancer victims.

 

Learn more about QGel
“Clinical applications will warrant a transition to more-defined and mechanically-dynamic matrices to fully exploit the potential of organoid technologies.“
Dutta, D., Heo, I., Clevers, H., Disease Modeling in Stem Cell-Derived 3D Organoid Systems. Trends in Molecular Medicine (2017)
“The full potential of organoids in research and therapy has remained unrealized, owing to the poorly defined animal-derived matrices in which they are grown.“
Gjorevski, N. et al., Designer matrices for intestinal stem cell and organoid culture. Nature (2016)
“Half of the secret of the cell lies outside the cell.“
Bissell MJ, Modelling Molecular Mechanisms of Breast Cancer and Invasion: Lessons from the Normal Gland. Biochemical Society transactions (2007)
“Scientists are starting to realize just how much a cell’s context matters.“
Bissell MJ, Abbott, A et al. Cell culture: Biology’s new dimension. Nature. (2003)
2019 September 4-6
PREDICT: 3D Tissue Models

Boston, MA

Will you be at the PREDICT: 3D Tissue Models in Boston, Massachusetts?  Contact us below if you would like to meet someone from the QGel team

2019 August 25-27
Cell Symposia | Engineering Organoids and Organs

San Diego, California

Will you be at the Cell Symposia Conference in San Diego, California?  Contact us below if you would like to meet someone from the QGel team

2019 June 23-25
Swiss Precision Medicine Oncology Conference

Basel, Switzerland

Will you be at the Swiss Precision Medicine Oncology Conference in Basel, Switzerland?  Contact us below if you would like to meet someone from the QGel team

2019 November 26-27
8th Swiss Cancer Center Leman (SCCL)

Lausanne, Switzerland

Will you be at the 8th Swiss Cancer Center Leman in Lausanne, Switzerland?  Contact us below if you would like to meet someone from the QGel team

2019 July 2-4
Lunch@Labs EPFL

Lausanne, Switzerland

Will you be at Lunch@Labs in Lausanne, Switzerland?  Contact us below if you would like to meet someone from the QGel team

QGel
Contact us